Form 10-Q Tonix Pharmaceuticals For: Sep 30

Go back to Form 10-Q Tonix Pharmaceuticals For: Sep 30

Tonix Pharmaceuticals (TNXP) Misses Q3 EPS by 2c

November 10, 2014 9:20 AM EST

Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q3 EPS of ($0.71), $0.02 worse than the analyst estimate of ($0.69).

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.

... More